- Home
- BARK vs NNNN Comparison
BARK vs NNNN Comparison
Compare BARK & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- NNNN
- Stock Information
- Founded
- BARK 2011
- NNNN 2021
- Country
- BARK United States
- NNNN Germany
- Employees
- BARK N/A
- NNNN N/A
- Industry
- BARK Department/Specialty Retail Stores
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BARK Consumer Discretionary
- NNNN Health Care
- Exchange
- BARK Nasdaq
- NNNN Nasdaq
- Market Cap
- BARK 244.9M
- NNNN 267.7M
- IPO Year
- BARK N/A
- NNNN 2025
- Fundamental
- Price
- BARK $1.16
- NNNN $6.43
- Analyst Decision
- BARK Buy
- NNNN
- Analyst Count
- BARK 2
- NNNN 0
- Target Price
- BARK $2.50
- NNNN N/A
- AVG Volume (30 Days)
- BARK 542.2K
- NNNN 28.8K
- Earning Date
- BARK 06-02-2025
- NNNN 01-01-0001
- Dividend Yield
- BARK N/A
- NNNN N/A
- EPS Growth
- BARK N/A
- NNNN N/A
- EPS
- BARK N/A
- NNNN 0.06
- Revenue
- BARK $490,256,000.00
- NNNN $8,185,146.00
- Revenue This Year
- BARK $3.12
- NNNN N/A
- Revenue Next Year
- BARK $7.76
- NNNN N/A
- P/E Ratio
- BARK N/A
- NNNN $118.17
- Revenue Growth
- BARK N/A
- NNNN 21.95
- 52 Week Low
- BARK $1.09
- NNNN $5.18
- 52 Week High
- BARK $2.56
- NNNN $7.82
- Technical
- Relative Strength Index (RSI)
- BARK 39.07
- NNNN N/A
- Support Level
- BARK $1.09
- NNNN N/A
- Resistance Level
- BARK $1.15
- NNNN N/A
- Average True Range (ATR)
- BARK 0.05
- NNNN 0.00
- MACD
- BARK 0.01
- NNNN 0.00
- Stochastic Oscillator
- BARK 36.84
- NNNN 0.00
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.